Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncology Hematology Care ("OHC") is one of the largest independent oncology practices in the United States. It provides comprehensive outpatient treatment for nearly all forms of adult cancers and complex blood disorders. OHC offers advanced medical oncology services—including chemotherapy, immunotherapy, targeted therapy—as well as radiation oncology, gynecologic oncology surgery, palliative care/hospice services. The practice has a robust clinical trials program through its partnership with Sarah Cannon Research Institute ("SCRI"), giving patients access to over a thousand ongoing studies across all phases. OHC’s team includes more than fifty expert providers operating at multiple locations throughout Greater Cincinnati. The group has been recognized for innovation in patient-centered care delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncology Hematology Care.